Designed for patients with long-standing persistent Afib, the EPi-Sense ST™ System is the only FDA-approved device for minimally invasive ablation therapy to treat LSPAF.
Discover how EPi-Sense ST™ is helping address the most prevalent and undertreated Afib population: https://okt.to/TzXedu
#HybridAFTherapy#CardiacSurgery
If you enjoy being a part of a cutting-edge medical device development team, check out our Biomedical Engineer opening. This role will design, develop, and test medical components and equipment for the next generation of AtriCure products.
Check out our career page to learn more! https://okt.to/LBRgma
Thanks to Cryo Nerve Block, post-op recovery doesn’t have to be the same from one generation to the next. Watch Justin share how his uncle’s pleurodesis recovery made him nervous—until he experienced a much different, smoother transition back to his everyday life.
Learn more about #cryoNB: https://okt.to/2IyzT3
Happy 4th of July! Today we take a moment to appreciate the independence we enjoy and the freedoms that shape our everyday lives. Wishing everyone a safe and happy holiday.
#IndependenceDay#FourthOfJuly
From concept to commercialization, women at AtriCure are driving innovation and shaping the future of medical technology. We're proud to celebrate their impact today and every day.
#WomeninEngineeringDay#WomeninSTEM
We honor the resilience and unwavering courage of those who have fought tirelessly against injustice; paving the way for lasting change.
#Juneteenth#FreedomDay
It’s not every day you get to meet someone whose life was impacted by your work. For AtriCure Director of Clinical Affairs, Denise, a classroom presentation turned into something unforgettable when a student shared that he had received Cryo Nerve Block Therapy for his Nuss procedure.
Moments like these remind us why we do what we do.
#PainManagement#cryoNB
Thanks to #cryoNB, post-op recovery doesn’t have to be the same from one generation to the next. Watch Justin share how his uncle’s pleurodesis recovery made him nervous—until he experienced a much different, smoother transition back to everyday life.
Learn more:
In the DEEP Trial, 62.4% of patients with Advanced Afib* who underwent hybrid ablation combined with left atrial appendage exclusion using AtriClip® remained free from atrial arrhythmias** at 2 years follow-up.
*Persistent or long-standing persistent Afib.
**Effectiveness was
Hear from cardiothoracic surgeon Dr. John Ofenloch as he shares his experience using the EnCompass® Clamp and what sets it apart in surgical ablation.
Discover more about EnCompass: https://t.co/ZLdcc2BNY6
#Ablation#CardioTwitter
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
AtriClip FLEX∙V® Device Animation
Duration: 2:9
AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion
Duration: 3:47
Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices
Duration: 1:25
AtriCure: Impacting Lives, One Patient at a Time
Duration: 6:9
social media channels to keep updated on the latest at AtriCure.